Gene expression profiling of archival tongue squamous cell carcinomas provides sub-classification based on DNA repair genes

International Journal of Oncology

Volumn 35, Issue 6, 2009, Pages 1321-1330

  Rentoft, Matilda ^a   Laurell, Göran ^b   Coates, Philip John ^c   Sjöström, Björn ^b   Nylander, Karin ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Formalin fixed paraffin embedded; Microaray; Squamous cell carcinoma of the head and neck; Tongue; Young adults

Indexed keywords

ALCOHOL CONSUMPTION; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DNA REPAIR; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA ANALYSIS; RNA DEGRADATION; SMOKING; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; UNINDEXED SEQUENCE; ADULT; AGED; CANCER STAGING; CLASSIFICATION; DNA MICROARRAY; FEMALE; GENETICS; MALE; MIDDLE AGED; ONSET AGE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TONGUE TUMOR;

MESSENGER RNA;

ADULT; AGE OF ONSET; AGED; CARCINOMA, SQUAMOUS CELL; DNA REPAIR; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TONGUE NEOPLASMS;

EID: 73949143506     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000450     Document Type: Article

References (60)

1. Blot WJ, McLaughlin JK, Winn DM, et al: Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48: 3282-3287, 1988.
2. Sturgis EM, Wei Q, and Spitz MR: Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol 31: 726-733, 2004.
3. Jovanovic A, Schulten EA, Kostense PJ, Snow GB and van der Waal I: Tobacco and alcohol related to the anatomical site of oral squamous cell carcinoma. J Oral Pathol Med 22: 459-462, 1993.
4. Mellin H, Friesland S, Lewensohn R, Dalianis T and Munck-Wikland E: Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89: 300-304, 2000.
5. Rautava J, Luukkaa M, Heikinheimo K, Alin J, Grenman R and Happonen RP: Squamous cell carcinomas arising from different types of oral epithelia differ in their tumor and patient characteristics and survival. Oral Oncol 43: 911-919, 2007.
6. Ziober AF, Patel KR, Alawi F, et al: Identification of a gene signature for rapid screening of oral squamous cell carcinoma. Clin Cancer Res 12: 5960-5971, 2006.
7. Annertz K, Anderson H, Biorklund A, et al: Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer 101: 95-99, 2002.
8. Macfarlane GJ, Boyle P, and Scully C: Oral cancer in Scotland: changing incidence and mortality. BMJ 305 1121-1123, 1992.
9. Plesko I, Macfarlane GJ, Evstifeeva TV, Obsitnikova A and Kramarova E: Oral and pharyngeal cancer incidence in Slovakia 1968-1989. Int J Cancer 56: 481-486, 1994.
10. Schantz SP and Yu GP: Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 128: 268-274, 2002.
11. McGregor GI, Davis N and Robins RE: Squamous cell carcinoma of the tongue and lower oral cavity in patients under 40 years of age. Am J Surg 146: 88-92, 1983.
12. Sarkaria JN and Harari PM: Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy. Head Neck 16: 107-111, 1994.
13. Garavello W, Spreafico R and Gaini RM: Oral tongue cancer in young patients: a matched analysis. Oral Oncol 43: 894-897, 2007.
14. Atula S, Grenman R, Laippala P and Syrjanen S: Cancer of the tongue in patients younger than 40 years. A distinct entity? Arch Otolaryngol Head Neck Surg 122: 1313-1319, 1996.
15. Pitman KT, Johnson JT, Wagner RL and Myers EN: Cancer of the tongue in patients less than forty. Head Neck 22: 297-302, 2000.
16. Verschuur HP, Irish JC, O'Sullivan B, Goh C, Gullane PJ and Pintilie M: A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck. Laryngoscope 109: 249-258, 1999.
17. Akervall JA, Michalides RJ, Mineta H, et al: Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 79: 380-389, 1997.
18. Geisler SA, Olshan AF, Weissler MC, et al: p16 and p53 protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res 8: 3445-3453, 2002.
19. Laimer K, Spizzo G, Gastl G, et al: High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncol 43: 193-198, 2007.
20. Bittner M, Meltzer P, Chen Y, et al: Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406: 536-540, 2000.
21. Golub TR, Slonim DK, Tamayo P, et al: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537, 1999.
22. Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL and van't Veer LJ: Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 100: 15901-15905, 2003.
23. Belbin TJ, Singh B, Barber I, et al: Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 62: 1184-1190, 2002.
24. Masuda N, Ohnishi T, Kawamoto S, Monden M and Okubo K: Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res 27: 4436-4443, 1999.
25. von Ahlfen S, Missel A, Bendrat K and Schlumpberger M: Determinants of RNA quality from FFPE samples. PLoS ONE 2: e1261, 2007.
26. Clark-Langone KM, Wu JY, Sangli C, et al: Biomarker discovery for colon cancer using a 761 gene RT-PCR assay. BMC Genomics 8: 279, 2007.
27. Penland SK, Keku TO, Torrice C, et al: RNA expression analysis of formalin-fixed paraffin-embedded tumors. Lab Invest 87: 383-391, 2007.
28. Bibikova M, Talantov D, Chudin E, et al: Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Am J Pathol 165: 1799-1807, 2004.
29. Fan JB, Yeakley JM, Bibikova M, et al: A versatile assay for high-throughput gene expression profiling on universal array matrices. Genome Res 14: 878-885, 2004.
30. Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
31. Specht K, Richter T, Muller U, Walch A and Hofler MW: Quantitative gene expression analysis in microdissected archival tissue by real-time RT-PCR. J Mol Med 78: B27, 2000.
32. Beskow C, Agren-Cronqvist AK, Granath F, Frankendal B and Lewensohn R: Pathologic complete remission after preoperative intracavitary radiotherapy of cervical cancer stage Ib and IIa is a strong prognostic factor for long-term survival: analysis of the Radiumhemmet data 1989-1991. Int J Gynecol Cancer 12: 158-170, 2002.
33. Friesland S, Fernberg JO, Lundell G, Munck-Wikland E, Strander H and Lewensohn R: Prognostic impact of complete remission after preoperative irradiation of tonsillar carcinoma: a retrospective analysis of the radiumhemmet data, 1980-1995. Int J Radiat Oncol Biol Phys 45: 1259-1266, 1999.
34. Eisen MB, Spellman PT, Brown PO and Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868, 1998.
35. Kornberg LJ, Villaret D, Popp M, et al: Gene expression profiling in squamous cell carcinoma of the oral cavity shows abnormalities in several signaling pathways. Laryngoscope 115: 690-698, 2005.
36. Llewellyn CD, Linklater K, Bell J, Johnson NW and Warnakulasuriya KA: Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. Oral Oncol 39: 106-114, 2003.
37. Gutschalk CM, Herold-Mende CC, Fusenig NE and Mueller MM: Granulocyte colony-stimulating factor and granulocytemacrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer Res 66: 8026-8036, 2006.
38. Ruokolainen H, Paakko P and Turpeenniemi-Hujanen T: Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis. Clin Cancer Res 10: 3110-3116, 2004.
39. Shi Z and Stack MS: Urinary-type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity. Biochem J 407: 153-159, 2007.
40. Mehra R, Cohen RB and Harari PM: EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Curr Oncol Rep 10: 176-184, 2008.
41. Hotz MA, Bosq J, Zbaeren P, et al: Spontaneous apoptosis and the expression of p53 and Bcl-2 family proteins in locally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 125: 417-422, 1999.
42. Rhodes DR, Yu J, Shanker K, et al: ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6: 1-6, 2004.
43. Chung CH, Parker JS, Karaca G, et al: Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5: 489-500, 2004.
44. Kathpalia VP, Mussak EN, Chow SS, et al: Genome-wide transcriptional profiling in human squamous cell carcinoma of the skin identifies unique tumor-associated signatures. J Dermatol 33: 309-318, 2006.
45. Kim JK, Kim KD, Lee E, et al: Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line. Cancer Lett 212: 61-70, 2004.
46. Torikai H, Akatsuka Y, Yatabe Y, et al: Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells: application for allogeneic transplantation. Int J Hematol 87: 467-473, 2008.
47. Mallick S, Patil R, Gyanchandani R, et al: Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1. J Pathol 217: 398-407, 2009.
48. Koch WM, Lango M, Sewell D, Zahurak M and Sidransky D: Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 109: 1544-1551, 1999.
49. O'Regan EM, Timon C, Sheils O, Codd M, O'Leary JJ and Toner M: Squamous cell carcinoma of the head and neck in young Irish adults. Br J Oral Maxillofac Surg 44: 203-206, 2006.
50. Liang XH, Lewis J, Foote R, Smith D and Kademani D: Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. J Oral Maxillofac Surg 66: 1875-1880, 2008.
51. Ringstrom E, Peters E, Hasegawa M, Posner M, Liu M and Kelsey KT: Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 8: 3187-3192, 2002.
52. O'Regan EM, Toner ME, Finn SP, et al: p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Hum Pathol 39: 452-458, 2008.
53. Khanna KK and Jackson SP: DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27: 247-254, 2001.
54. Wynne P, Newton C, Ledermann JA, Olaitan A, Mould TA and Hartley JA: Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy. Br J Cancer 97: 927-933, 2007.
55. Warnecke-Eberz U, Metzger R, Miyazono F, et al: High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer. Clin Cancer Res 10: 3794-3799, 2004.
56. Hickson I, Zhao Y, Richardson CJ, et al: Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 64: 9152-9159, 2004.
57. Jones KR, Gewirtz DA, Yannone SM, et al: Radiosensitization of MDA-MB-231 breast tumor cells by adenovirus-mediated overexpression of a fragment of the XRCC4 protein. Mol Cancer Ther 4: 1541-1547, 2005.
58. Sak A, Stueben G, Groneberg M, Bocker W and Stuschke M: Targeting of Rad51-dependent homologous recombination: implications for the radiation sensitivity of human lung cancer cell lines. Br J Cancer 92: 1089-1097, 2005.
59. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
60. Farmer H, McCabe N, Lord CJ, et al: Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917-921, 2005.